Walleye Trading LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Walleye Trading LLC

  • $46.7 Billion
  • Q3 2024

Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $248,472 - $337,824
3,600 Added 150.0%
6,000 $421,000
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $952,704 - $1.18 Million
-12,800 Reduced 84.21%
2,400 $197,000
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $284,954 - $336,600
-3,400 Reduced 18.28%
15,200 $1.33 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $967,994 - $1.25 Million
12,700 Added 215.25%
18,600 $1.79 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $6.46 Million - $7.17 Million
-75,900 Reduced 92.79%
5,900 $522,000
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $2.01 Million - $2.33 Million
-23,200 Reduced 22.1%
81,800 $7.09 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $2.77 Million - $3.71 Million
31,600 Added 43.05%
105,000 $10.2 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $3.35 Million - $4.5 Million
41,400 Added 129.38%
73,400 $7.6 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $928,408 - $1.1 Million
-11,300 Reduced 26.1%
32,000 $2.71 Million
Q2 2022

Aug 08, 2022
BUY
$71.48 - $86.85 $2.22 Million - $2.69 Million
31,000 Added 252.03%
43,300 $3.59 Million
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $661,092 - $824,941
8,900 Added 261.76%
12,300 $948,000
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $286,880 - $365,880
-4,000 Reduced 54.05%
3,400 $300,000
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $321,511 - $367,521
4,300 Added 138.71%
7,400 $572,000
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $29,892 - $36,276
-400 Reduced 11.43%
3,100 $234,000
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $50,827 - $63,140
700 Added 25.0%
3,500 $307,000
Q3 2020

Nov 16, 2020
SELL
$71.87 - $131.03 $323,415 - $589,635
-4,500 Reduced 61.64%
2,800 $213,000
Q2 2020

Aug 14, 2020
BUY
$79.55 - $124.22 $23,865 - $37,266
300 Added 4.29%
7,300 $900,000
Q1 2020

May 15, 2020
BUY
$71.37 - $96.85 $449,631 - $610,155
6,300 Added 900.0%
7,000 $592,000
Q4 2019

Feb 14, 2020
SELL
$64.27 - $86.37 $1.55 Million - $2.08 Million
-24,100 Reduced 97.18%
700 $59,000
Q3 2019

Nov 14, 2019
BUY
$67.4 - $85.11 $1.11 Million - $1.4 Million
16,500 Added 198.8%
24,800 $1.67 Million
Q2 2019

Aug 14, 2019
SELL
$80.35 - $93.9 $2.27 Million - $2.65 Million
-28,200 Reduced 77.26%
8,300 $711,000
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $2.53 Million - $2.96 Million
30,000 Added 461.54%
36,500 $3.24 Million
Q4 2018

Feb 14, 2019
BUY
$80.14 - $106.07 $200,350 - $265,175
2,500 Added 62.5%
6,500 $553,000
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $206,624 - $232,584
-2,200 Reduced 35.48%
4,000 $388,000
Q1 2018

May 15, 2018
BUY
$77.67 - $92.63 $403,884 - $481,676
5,200 Added 520.0%
6,200 $503,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,000
1,000 $91,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email